Astria Therapeutics, Inc.ATXSNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +101.45% | +54.52% | +10.92% | +2.69% | +2.69% |
| Weighted Average Shares Diluted Growth | +101.45% | +54.52% | +10.92% | +2.69% | +2.69% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +86.55% | +34.44% | -18.06% | -23.39% | -24.82% |
| Book Value per Share Growth | -8.07% | -15.01% | -29.08% | -26.91% | -33.52% |
| Debt Growth | +1055.33% | +1527.05% | +2913.69% | -17.67% | -20.91% |
| R&D Expense Growth | +53.77% | -24.96% | +76.69% | +25.28% | +17.74% |
| SG&A Expenses Growth | +23.28% | +30.13% | +9.32% | +22.00% | +25.36% |